
HomeSpecialty IngredientJointAlive® by Chenland Nutritionals
JointAlive® by Chenland Nutritionals
JointAlive® by Chenland Nutritionals
JointAlive® by Chenland is a standardized botanical blend composed of Epimedium brevicornum leaves, Dioscorea nipponica rhizomes, and Salvia miltiorrhiza roots. The formula is standardized to icariin, diosgenin, and tanshinone IIA using HPLC methods and supported by multiple human clinical and preclinical studies. JointAlive® is allergen-free, non-GMO, halal, and kosher, and suitable for capsule and tablet formulations requiring low-dose, joint-focused active systems.
0
0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Technology:
Name:
JointAlive®
Ingredient/s:
Joint Health, Anti-Inflammation, Anti-Aging, Recovery
Categories:
Joint Health, Bone Health, Anti-Inflammation
Dosage (min):
300 mg
Dosage (max):
600 mg
MOQ:
Price kg:
Botanical Names:
Epimedium brevicornum Maxim., Dioscorea nipponica Makino., Salvia miltiorrhiza Bge.
Active/s:
Icariin, Diosgenin, Tanshinone IIA
Assay:
Standardized Icariin ≥2.2%, Diosgenin ≥5.3%, Tanshinone IIA ≥0.2%
Country of Origin:
Suppliers:
Chenland Nutritionals
Contact Information
Email:
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Ingredient Overview
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Ingredient Highlights
JointAlive® features clinically supported actives shown to help:
- Support joint comfort during daily movement.*
- Improve joint flexibility and mobility.*
- Support healthy inflammatory response to activity.*
- Promote joint function in active individuals.*
- Enhance cartilage integrity and support.*
- Support recovery after physical exertion.*
Featured Content
Product type
Endorsement
0
0 out of 5 stars (based on 0 endorsements)
Excellent
Very good
Average
Poor
Terrible
There are no reviews yet. Be the first one to write one.












